Crossmark

Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cells

Crossref DOI link: https://doi.org/10.1007/s12185-021-03213-8

Published Online: 2021-09-13

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fujiwara, Hiroshi https://orcid.org/0000-0003-3340-6915
License Information

Text and Data Mining valid from 2021-09-13

Version of Record valid from 2021-09-13
More Information

Article History

Received: 18 August 2021

Revised: 18 August 2021

Accepted: 27 August 2021

First Online: 13 September 2021

Free to read: This content has been made available to all.